UBX – unity biotechnology, inc. (US:NASDAQ)
Stock Stats
News
UNITY Biotechnology Announces Upcoming Presentations at the ARVO 2024 Annual Meeting
ASCO 2024 | Ascentage Pharma to Present Four Studies, Including an Oral Report Featuring the Latest Data of Olverembatinib in SDH-Deficient GIST [Yahoo! Finance]
UNITY Biotechnology Announces Extension of Phase 2b ASPIRE Clinical Study Evaluating UBX1325 in DME
Unity Biotechnology, Inc. (NASDAQ: UBX) had its price target lowered by analysts at HC Wainwright from $10.00 to $8.00. They now have a "buy" rating on the stock.
UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates [Yahoo! Finance]
Form 4 Unity Biotechnology, For: May 02 Filed by: Ghosh Anirvan
Form ARS Unity Biotechnology, For: Dec 31
Form DEFA14A Unity Biotechnology,
Form DEF 14A Unity Biotechnology, For: Jun 21
Form S-8 Unity Biotechnology,
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.